12/02/2022
7:13 AM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2022
4:03 PM | Anavex Life Sciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
06/29/2022
4:23 PM | Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2022
4:14 PM | Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2022
4:08 PM | Anavex Life Sciences (Issuer)
Ma Jiong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2022
4:10 PM | Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/29/2022
4:12 PM | Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2022
4:08 PM | Anavex Life Sciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/27/2022
7:30 PM | Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2022
3:30 PM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2022
3:31 PM | Anavex Life Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/13/2021
6:19 AM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/04/2021
4:30 PM | Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2021
4:36 PM | Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2021
4:38 PM | Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2021
4:40 PM | Anavex Life Sciences (Issuer)
Ma Jiong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2021
4:26 PM | Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2021
4:19 PM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2021
4:22 PM | Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2021
8:48 PM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2021
8:45 PM | Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2021
8:53 PM | Anavex Life Sciences (Issuer)
Ma Jiong (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/28/2021
3:00 PM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/25/2021
8:30 PM | Anavex Life Sciences (Issuer)
FAVUS ELLIOT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2021
7:47 AM | Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2021
3:29 PM | Anavex Life Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/09/2021
4:06 PM | Anavex Life Sciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2021
8:31 PM | Anavex Life Sciences (Issuer)
FAVUS ELLIOT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2021
12:22 PM | Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2021
1:22 PM | Anavex Life Sciences (Issuer)
FAVUS ELLIOT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2021
1:24 PM | Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2021
1:26 PM | Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2021
1:28 PM | Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2021
1:29 PM | Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2021
1:17 PM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2021
1:20 PM | Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2020
4:27 PM | Anavex Life Sciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
12/28/2020
4:28 PM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2020
6:06 AM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2020
10:15 AM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/15/2020
6:02 AM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2020
3:08 PM | Anavex Life Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2020
3:32 PM | Anavex Life Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2020
6:06 AM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2020
3:30 PM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2020
5:00 PM | Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2020
5:00 PM | Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2020
5:00 PM | Anavex Life Sciences (Issuer)
FAVUS ELLIOT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2020
5:00 PM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2020
5:00 PM | Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2020
5:00 PM | Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2020
5:00 PM | Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2019
4:16 PM | Anavex Life Sciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
09/13/2019
4:10 PM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2019
3:31 PM | Anavex Life Sciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/12/2019
3:58 PM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2019
6:27 PM | Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2019
3:31 PM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2019
3:39 PM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2019
5:26 AM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2019
3:31 PM | Anavex Life Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
12/12/2018
3:39 PM | Anavex Life Sciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
10/09/2018
3:42 PM | Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2018
4:29 PM | Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2018
4:30 PM | Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2018
4:31 PM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2018
4:32 PM | Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2018
4:33 PM | Anavex Life Sciences (Issuer)
FAVUS ELLIOT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2018
4:27 PM | Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2018
4:06 PM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2018
4:23 PM | Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2018
4:16 PM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2018
11:35 AM | Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/20/2018
3:31 PM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/09/2018
2:16 PM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2018
4:00 PM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2018
10:01 AM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2018
1:06 PM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2018
7:56 AM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2017
3:09 PM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2017
3:11 PM | Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2017
4:14 PM | Anavex Life Sciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
